查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179898

2023-2030 年全球假肢和關節市場

Global Artificial Limbs and Joints Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

假肢可替代因外傷或先天缺陷而丟失的身體部位。 假肢的種類因人而異，如缺肢或截肢的原因，缺肢的部位等。

市場動態

全球假肢和關節市場受到技術進步、假肢和關節採用率增加、患者意識提高以及整容手術支出增加的推動。

肢體殘障人口增加，推動市場增長

由於患者意識的提高，對假肢和關節的需求不斷增加，這將在預測期內推動市場發展。 人類肢體的複雜性，尤其是上肢和手，使我們能夠與世界互動。 假肢技術、手術創新和康復增強的最新進展對於希望恢復到受傷前功能水平的肢體缺陷患者來說似乎很有希望。

根據 2022 年發表在 Prosthesis 上的一篇文章，全球有超過 4000 萬肢體截肢者，其中大多數人無法獲得任何形式的假肢治療。 世界衛生組織估計，上肢 (UL) 缺陷約佔該人口的 16%。 UL 遺傳方差的全球估計差異很大，範圍從 4 到 5/10,000 到 1/100 出生。 後天性截肢的病因多種多樣，但外傷往往是主要原因。

其他好處包括靜音、提高可靠性、縮短培訓週期、簡化維護、重量輕、成本適中、本體感受反饋和用戶身體移動以任意控制終端設備。一種簡單的打開和關閉的操作機制已被報導。 可選的閉合 BP 假體還為用戶提供擴展的生理本體感覺。 它將本體感覺擴展到用戶可能與之交互的工具。

與假肢和人工關節相關的問題阻礙了市場增長

但是，大多數可供患者使用的 UL 假肢既負擔不起，也常常適用於要求更高的環境。 合適的假肢問題對兒童和青少年來說更為尖銳，因為他們的選擇更少。 這些因素阻礙了市場的增長。

COVID-19 影響分析

COVID-19的出現對全球假肢和人工關節市場產生了重大影響。 根據 2020 年發表在 The Journal of Arthroplasty 上的一篇文章，COVID-19 大流行導致了限制大流行影響的特殊法規，影響了社會的各個方面。 醫療保健行業尤其受到影響。 ACS、CMS 和大多數州在 COVID-19 爆發期間僅建議或要求進行必要的外科手術。

但是，強制減少不必要的手術會對醫療保健系統產生重大影響。 此外，鑑於全髖關節和全膝關節置換手術在美國手術量中所佔的比重很大，這些政策很可能會影響到髖關節置換術的患者和照顧他們的醫療機構和醫療機構。這無疑是困難的。涉及的人。

然而，取消病例的再次手術數量預計會迅速增加的原因是全球對假肢和人工關節的需求正在增加。這被認為是因為患者希望接受手術的情況正在發生變化。恢復。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 老年人口增加
      • 交通事故和工傷事故增加
    • 約束因素
      • 從監管準則的角度來看進入壁壘
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 人工關節
  • 假肢

第八章技術

  • 裝飾假肢
  • 有線/電池供電的假肢
  • 電動/肌電假肢

第 9 章按應用

  • 人工膝關節
  • 人造骨盆
  • 人工肘
  • 假肩
  • 人造手臂
  • 假腿

第 10 章最終用戶

  • 醫院
  • 升序
  • 康復中心
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 按類型劃分的基準

第13章公司簡介

  • Arthrex 公司
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Depuy Synthes（Johnson & Johnson）（Johnson & Johnson）
  • Djo Surgical
  • Integra Lifesciences
  • Smith & Nephew
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Holdings Inc.
  • Ossur
  • Conmed Corporation

第14章 DataM

簡介目錄
Product Code: DMMD1647

Market Overview

The global artificial limbs and joints market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).

Artificial limbs, or prostheses, substitute a missing body part lost due to trauma or congenital deficiency. The type of prosthesis a person can use depends on the individual, including the reason for limb loss or amputation and the location of the missing extremity.

Market Dynamics

The global artificial limbs and the joint market is driven by technological advancements, the growing adoption of artificial limbs and joints, improving patient awareness, and rising expenditure on cosmetic procedures.

The increasing population of limb-deficient individuals drives the market growth

The rising demand for artificial limbs and joints due to increasing patient awareness drives the market in the forecast period. The complexity of the human extremity, particularly the upper extremity and the hand, allows us to interact with the world. Recent advances in prosthesis technology, surgical innovations, and enhanced rehabilitation appear promising for patients with limb loss who hope to return to their pre-injury level of function.

As per the article published in Prosthesis in 2022, There are over 40 million limb-deficient individuals worldwide, most of whom do not have access to any form of prosthetic care. The World Health Organization has estimated that upper-limb (UL) loss or absence accounts for about 16% of this population. Global estimates for genetic UL differences vary widely and range from 4 to 5/10,000 to 1/100 live births. Acquired UL amputations can be due to a wide variety of aetiologies, with the primary cause often being trauma.

In addition, the reported benefits of body-powered (BP) prostheses include silent action, increased reliability, reduced training period, simple maintenance, lightweight, moderate cost, proprioceptive feedback, and a simple operational mechanism that uses the body motions of the user to voluntary open or close the terminal device. Also, a voluntary closing BP prosthesis offers the user extended physiological proprioception. It extends the proprioceptive feedback to tools that users might engage with.

The issues associated with artificial limbs and joints will hamper the growth of the market

However, most UL prosthetics available to patients are often neither affordable nor applicable in more challenging environments. The issue of appropriate prosthetics is even more pressing for children and adolescents, as fewer options are available. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global artificial limbs and joints market. As per the article published in The Journal of Arthroplasty in 2020, the COVID-19 pandemic has resulted in exceptional restrictions to curb the pandemic's impact, impacting all aspects of society. The healthcare industry has been particularly affected. The ACS, the CMS, and most states have advised or required that only essential surgical procedures be performed during the COVID-19 outbreak.

However, this mandated reduction of unnecessary surgical procedures will profoundly impact the healthcare system. Furthermore, given that hip and knee arthroplasty comprise a substantial share of the surgical volume in the U.S., there is no doubt these policies are hard felt by hip and knee arthroplasty patients and the providers and institutions that care for them.

However, a predicted surge of rescheduling canceled cases is based on the assumption that patients will want to reschedule their surgery or new patients will want to be indicated for surgery, as the situation is recovering from COVID-19-results in the increasing demand for artificial limbs and joints worldwide.

Segment Analysis

The artificial knee segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial knee segment accounts for the largest market share. As per the article published in the Journal of clinical medicine 2021, total knee arthroplasty (TKA) is a very effective treatment for severe osteoarthritis. TKA leads to good results in returning to daily activities, good survival rates, and overall functional improvement. Technologies such as navigation, smart tools, patient-specific instrumentation (PSI), and computer or robotic-assisted surgery (CAS) aim to individualize the surgery and account for the anatomy and ligament balancing of each patient to improve the accuracy of the surgical planning in three dimensions (3D), to increase alignment accuracy and reliability, and improve implant positioning.

In addition, the key players are adopting market strategies such as product launches and collaboration to expand their business. For instance, in April 2022, Researchers at the Indian Institute of Technology-Madras (IIT-M) introduced India's first polycentric prosthetic knee. Named 'Kadam,' the indigenously designed prosthetic knee aims to enhance the quality of life of above-knee amputees.

Geographical Analysis

North America region holds the largest market share of the global artificial limbs and joints market

North America dominates the artificial limbs and joints market and is anticipated to show a parallel trend over the forecast period. The market is boosted by factors such as advanced healthcare infrastructure, the increasing incidence of injuries and accidents, active regional key players, and growing awareness about advanced prosthetic technologies in the North American region.

As per the article published in Current Reviews in Musculoskeletal Medicine in 2020, an estimated 1.6 million Americans were living with limb loss in 2005, with a projected increase to 3.6 million by 2050. Upper extremity limb loss accounts for approximately one-third of that group, though major amputations (those proximal to the digits) represent only 8% of upper extremity amputations. Trauma is the second main cause of amputation, occurring at approximately one-eighth of the amputation rate secondary to vascular disease.

As per the article published in Techniques in Orthopaedics in December 2021, presently, 2.1 million people in the U.S. live with limb loss, with 185,000 amputations happening each year. Amputation numbers are predicted to rise with increasing age, diabetes, and vascular disease in the population. Advances in surgical techniques and prosthetic technology have created the potential for amputees to live active and productive lives.

Competitive Landscape

The artificial limbs and joints market is a moderately competitive presence of local and global companies. Some key players contributing to the market's growth are Arthrex Inc, Depuy Synthes (Johnson & Johnson) (Johnson & Johnson), Djo Surgical, Integra Lifesciences, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Holdings Inc., Ossur, and Conmed Corporation, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the artificial limbs and joints market globally.

For instance,

  • In September 2021, the Cleveland Clinic-led international research team developed the bionic system that combines three important functions - intuitive motor control, touch and grip kinesthesia, and the intuitive feeling of opening and closing the hand. Collaborators included the University of Alberta and the University of New Brunswick.

Allergan plc

Overview:

Stryker Corporation is a medical device company founded in 1941 and headquartered in the United States. The company offers innovative products and services in neurotechnology, medical and surgical, orthopaedics and spine that help enhance patient and hospital outcomes.

Product Portfolio:

Accolade II: The company created Accolade II's Morphometric Wedge to manage modern demands with novel technology by developing a conventional tapered wedge femoral stem design with size-specific medial curvature to more closely fit an expansive range of bone sizes and shapes of today's patient population.

The global artificial limbs and joints market report would provide access to approximately 65+ market data tables, 60+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number of Geriatric Population
      • 4.1.1.2. Increasing Number of Road Mishaps and Work Place Incidents
    • 4.1.2. Restraints:
      • 4.1.2.1. Entry Barriers in Terms of Regulatory Guidelines
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Artificial Joints*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Artificial Limbs

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Cosmetic Prosthetics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cable-operated/Battery-powered Prosthetics
  • 8.4. Electrically-powered/Myoelectric Prosthetics

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Artificial Knee*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Artificial Hip
  • 9.4. Artificial Elbow
  • 9.5. Artificial Shoulder
  • 9.6. Artificial Arm
  • 9.7. Artificial Leg

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. ASCs
  • 10.4. Rehabilitation Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Arthrex Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Depuy Synthes (Johnson & Johnson) (Johnson & Johnson)
  • 13.3. Djo Surgical
  • 13.4. Integra Lifesciences
  • 13.5. Smith & Nephew
  • 13.6. Stryker Corporation
  • 13.7. Wright Medical Group
  • 13.8. Zimmer Holdings Inc.
  • 13.9. Ossur
  • 13.10. Conmed Corporation

LIST NOT EXHAUSTIVE

14. Global Artificial Limbs and Joints Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us